Neurochemical and behavioural effects of acute administration of pioglitazone in the MPTP model of Parkinson's disease

被引：0
|
作者：
Barbiero, J. [1 ]
Moraes, L. [1 ]
Lima, M. [1 ]
Andreatini, R. [1 ]
Santiago, R. [1 ]
Vital, M. [1 ]
机构：
[1] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2011年 / 21卷
关键词：
D O I：
10.1016/S0924-977X(11)70397-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S256 / S256
页数：1
相关论文
共 50 条
  • [31] Towards an MPTP model of psychosis in Parkinson's disease
    Fox, S. H.
    Gomez-Ramirez, J.
    Johnston, T.
    Voon, V.
    Brotchie, J. M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 290 - 290
  • [32] Amiloride is neuroprotective in an MPTP model of Parkinson's disease
    Arias, Robert L.
    Sung, Mei-Li A.
    Vasylyev, Dmytro
    Zhang, Mei-Yi
    Albinson, Kristin
    Kubek, Katie
    Kagan, Natasha
    Beyer, Chad
    Lin, Qian
    Dwyer, Jason M.
    Zaleska, Margaret M.
    Bowlby, Mark R.
    Dunlop, John
    Monaghan, Michael
    NEUROBIOLOGY OF DISEASE, 2008, 31 (03) : 334 - 341
  • [33] Modeling Parkinson's Disease in Primates: The MPTP Model
    Porras, Gregory
    Li, Qin
    Bezard, Erwan
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (03):
  • [34] Development of a MPTP model of Parkinson's disease in zebrafish
    Salzmann, J.
    Anichtchik, O.
    Best, J.
    Richards, F.
    Fleming, A.
    Roach, A.
    Goldsmith, P.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 541 - 541
  • [35] PET studies in the MPTP model of Parkinson's disease
    Doudet, DJ
    PARKINSON'S DISEASE, 2001, 86 : 187 - 195
  • [36] Protocol for the MPTP mouse model of Parkinson's disease
    Vernice Jackson-Lewis
    Serge Przedborski
    Nature Protocols, 2007, 2 : 141 - 151
  • [37] Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats
    Perry, JC
    Da Cunha, C
    Anselmo-Franci, J
    Andreatini, R
    Miyoshi, E
    Tufik, S
    Vital, MABF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 484 (2-3) : 225 - 233
  • [38] Effects of plant hexase glycoside GG17 on behavioral and neurochemical abnormalities in the MPTP-induced animal model of Parkinson's disease
    Kalinina, TS
    Nerobkova, LN
    Voronina, TA
    Kudrin, VS
    Klodt, PM
    Narkevich, VB
    Litvin, AA
    Stovbun, SV
    Sergienko, VI
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S93 - S94
  • [39] The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
    Quinn, L. P.
    Crook, B.
    Hows, M. E.
    Vidgeon-Hart, M.
    Chapman, H.
    Upton, N.
    Medhurst, A. D.
    Virley, D. J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (01) : 226 - 233
  • [40] Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson’s disease
    Zhongmei Chen
    Yunpeng Yang
    Xu Yang
    Changqing Zhou
    Fengqun Li
    Peng Lei
    Ling Zhong
    Xin Jin
    Guoguang Peng
    Neurological Sciences, 2013, 34 : 1559 - 1570
12345